Flash FinanceUS
Market open S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · AIM ImmunoTech Inc. (AIM)

AIM ImmunoTech swaps about $450,000 of Streeterville note into 1.92 million shares

Neutral Impact 3 of 5 financing Written later

AIM ImmunoTech Inc. exchanged about $450,000 of a November 18, 2025 promissory note held by Streeterville Capital, LLC for 1,921,441 shares of common stock, at an average conversion price of about $0.234 per share, under agreements dated September 3 and September 4, 2026. Stockholders had approved the conversion at a July 15, 2026 special meeting, and the shares were issued without SEC registration under a Section 3(a)(9) exemption.

Key points

  • Converted about $450,000 of the November 18, 2025 promissory note into 1,921,441 shares
  • Average conversion price of about $0.234 per share
  • Agreements signed September 3 and September 4, 2026 with Streeterville Capital, LLC
  • Stockholders approved the conversion at a special meeting held July 15, 2026

The filing

CompanyAIM ImmunoTech Inc. (AIM)
Form8-K, current report
Filed with the SECSep 10, 2026, 4:35 PM ET
Accession number0001493152-26-042196

Items reported: 1.01 Material Definitive Agreement3.02 Unregistered Equity Sale

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 8:29 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on September 10, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.